Erratum to ‘The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families’ [The Breast 73 (2024) 103611]
Maartje A.C. Schreurs,
Teresa Ramón y Cajal,
Muriel A. Adank,
J. Margriet Collée,
Antoinette Hollestelle,
Jeroen van Rooij,
Marjanka K. Schmidt,
Maartje J. Hooning
Affiliations
Maartje A.C. Schreurs
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
Teresa Ramón y Cajal
Familial Cancer Clinic, Medical Oncology Service, Hospital Sant Pau, Barcelona, Spain
Muriel A. Adank
Department of Clinical Genetics, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands
J. Margriet Collée
Department of Clinical Genetics, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
Antoinette Hollestelle
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
Jeroen van Rooij
Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands
Marjanka K. Schmidt
Division of Molecular Pathology, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands
Maartje J. Hooning
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Corresponding author.